Le Lézard
Classified in: Health
Subject: RCL

Voluntary Class 1 Recall Announced for Limited Number of PLANTERS® 4 oz. Honey Roasted Peanuts and 8.75 oz. PLANTERS® Deluxe Lightly Salted Mixed Nuts Distributed to Two Retail Locations in Five States


No reports of consumer illnesses and no other PLANTERS® products are involved in this voluntary recall. 

AUSTIN, Minn., May 2, 2024 /PRNewswire/ -- Hormel Foods Sales, LLC is voluntarily recalling two varieties of PLANTERS® products that were produced at one of its facilities in April. This recall only impacts two retailers in five states. These products are being recalled out of an abundance of caution because they have the potential to be contaminated with Listeria monocytogenes, an organism that can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain, and diarrhea. Listeria infection can cause miscarriages and stillbirths among pregnant women. No other PLANTERS® products or retailers are involved in this recall.

There have been no reports of illness related to this recall to date, and all retailers that received the affected product have been properly notified. This recall is being initiated with the knowledge of the US Food and Drug Administration.

The products were only shipped to Publix distribution warehouses in Florida, Georgia, Alabama and North Carolina and to Dollar Tree distribution warehouses in South Carolina and Georgia.

The recalled product is limited to (1) 4 oz. packages of PLANTERS® Honey Roasted Peanuts with a "Best If Used By" date of April 11, 2025 (displayed on package as 04 11 25) and a package UPC code of 2900002097 and (2) 8.75 oz. cans of PLANTERS® Deluxe Lightly Salted Mixed Nuts with a "Best If Used By" date of April 5, 2026 (displayed on the bottom of the can as 05APR26) and a package UPC code of 2900001621 on the side of the can. Photos of the products, "Best If Used By" dates and UPC codes appear below.

No other sizes, varieties, or other packaging configurations of PLANTERS® brand products are included in this recall.

If a consumer has this product, they can discard the product or return it to the store where purchased for an exchange. If consumers have questions, they may contact Hormel Foods Customer Relations via email here, via chat at https://www.planters.com/ or at 1-800-523-4635, Monday-Friday, 8 a.m. ? 11 a.m. and 2 p.m. ? 4 p.m. Central Time, excluding holidays.

Contact:           

Media Relations


Hormel Foods


[email protected]

SOURCE Hormel Foods Corporation


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: